BCRX logo

BioCryst Pharmaceuticals (BCRX) Long term debt

Annual long term debt:

$805.97M-$16.53M(-2.01%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual long term debt is $805.97 million, with the most recent change of -$16.53 million (-2.01%) on December 31, 2024.
  • During the last 3 years, BCRX annual long term debt has risen by +$214.55 million (+36.28%).
  • BCRX annual long term debt is now -2.01% below its all-time high of $822.50 million, reached on December 31, 2023.

Performance

BCRX Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Quarterly long term debt:

$792.12M-$13.85M(-1.72%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly long term debt is $792.12 million, with the most recent change of -$13.85 million (-1.72%) on March 31, 2025.
  • Over the past year, BCRX quarterly long term debt has dropped by -$32.02 million (-3.89%).
  • BCRX quarterly long term debt is now -6.05% below its all-time high of $843.15 million, reached on September 30, 2023.

Performance

BCRX Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

BCRX Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.0%-3.9%
3 y3 years+36.3%+29.7%
5 y5 years+1703.3%+1868.4%

BCRX Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.0%+36.3%-6.0%+425.6%
5 y5-year-2.0%+1703.3%-6.0%+2470.8%
alltimeall time-2.0%>+9999.0%-6.0%>+9999.0%

BCRX Long term debt History

DateAnnualQuarterly
Mar 2025
-
$792.12M(-1.7%)
Dec 2024
$805.97M(-2.0%)
$805.97M(-0.0%)
Sep 2024
-
$806.25M(-1.6%)
Jun 2024
-
$818.96M(-0.6%)
Mar 2024
-
$824.14M(+0.2%)
Dec 2023
$822.50M(+11.3%)
$822.50M(-2.4%)
Sep 2023
-
$843.15M(+2.2%)
Jun 2023
-
$825.10M(+9.6%)
Mar 2023
-
$752.87M(+1.9%)
Dec 2022
$739.08M(+25.0%)
$739.08M(+2.7%)
Sep 2022
-
$719.62M(+377.5%)
Jun 2022
-
$150.71M(-75.3%)
Mar 2022
-
$610.92M(+3.3%)
Dec 2021
$591.42M(+138.2%)
$591.42M(+331.4%)
Sep 2021
-
$137.09M(+4.7%)
Jun 2021
-
$130.90M(+3.1%)
Mar 2021
-
$126.92M(-48.9%)
Dec 2020
$248.32M(+455.6%)
$248.32M(+705.9%)
Sep 2020
-
$30.81M(-13.3%)
Jun 2020
-
$35.55M(-11.7%)
Mar 2020
-
$40.24M(-10.0%)
Dec 2019
$44.70M(+59.2%)
$44.70M(-9.9%)
Sep 2019
-
$49.58M(-7.5%)
Jun 2019
-
$53.59M(+8.0%)
Mar 2019
-
$49.62M(+76.7%)
Dec 2018
$28.07M(+44.0%)
$28.07M(-9.4%)
Sep 2018
-
$31.00M(+91.6%)
Jun 2018
-
$16.18M(-9.3%)
Mar 2018
-
$17.84M(-8.5%)
Dec 2017
$19.50M
$19.50M(-7.8%)
Sep 2017
-
$21.15M(-6.8%)
Jun 2017
-
$22.70M(-6.6%)
DateAnnualQuarterly
Mar 2017
-
$24.32M(-4.6%)
Dec 2016
$25.48M(+972.9%)
$25.48M(+0.6%)
Sep 2016
-
$25.34M(+878.8%)
Jun 2016
-
$2.59M(+3.3%)
Mar 2016
-
$2.51M(+5.5%)
Dec 2015
$2.38M(-92.1%)
$2.38M(-92.1%)
Mar 2014
-
$30.00M(0.0%)
Dec 2013
$30.00M(0.0%)
$30.00M(0.0%)
Sep 2013
-
$30.00M(0.0%)
Jun 2013
-
$30.00M(0.0%)
Mar 2013
-
$30.00M(0.0%)
Dec 2012
$30.00M(0.0%)
$30.00M(0.0%)
Sep 2012
-
$30.00M(0.0%)
Jun 2012
-
$30.00M(0.0%)
Mar 2012
-
$30.00M(0.0%)
Dec 2011
$30.00M(>+9900.0%)
$30.00M(0.0%)
Sep 2011
-
$30.00M(0.0%)
Jun 2011
-
$30.00M(0.0%)
Mar 2011
-
$30.00M(>+9900.0%)
Mar 2000
-
$2700.00(-97.3%)
Jun 1997
-
$100.00K(0.0%)
Dec 1996
$100.00K(-66.7%)
$100.00K(0.0%)
Sep 1996
-
$100.00K(0.0%)
Jun 1996
-
$100.00K(-50.0%)
Mar 1996
-
$200.00K(-33.3%)
Dec 1995
$300.00K(-50.0%)
$300.00K(-25.0%)
Sep 1995
-
$400.00K(0.0%)
Jun 1995
-
$400.00K(-20.0%)
Mar 1995
-
$500.00K(-16.7%)
Dec 1994
$600.00K
$600.00K(0.0%)
Sep 1994
-
$600.00K(-14.3%)
Jun 1994
-
$700.00K(-12.5%)
Mar 1994
-
$800.00K

FAQ

  • What is BioCryst Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual long term debt year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly long term debt year-on-year change?

What is BioCryst Pharmaceuticals annual long term debt?

The current annual long term debt of BCRX is $805.97M

What is the all time high annual long term debt for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual long term debt is $822.50M

What is BioCryst Pharmaceuticals annual long term debt year-on-year change?

Over the past year, BCRX annual long term debt has changed by -$16.53M (-2.01%)

What is BioCryst Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of BCRX is $792.12M

What is the all time high quarterly long term debt for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly long term debt is $843.15M

What is BioCryst Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, BCRX quarterly long term debt has changed by -$32.02M (-3.89%)
On this page